In comparison to the pronounced effects of adenovirally expressed IGFBP-5 in vitro using human primary lung fibroblasts [7,8] and ex vivo using human lung and skin tissues in fibrosis [5,9,12], the effects of transgenic expression of human IGFBP-5 in vivo were modest. The gene discussed is IGFBP5; the disease is fibrosis.